J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Learn more at jlee.com. Just like a doctor checks vital signs to assess a patient’s health, company culture serves as a ...

Providing compassionate care isn't just a choice that health care workers make; it requires larger systems and leaders to ...

We’re pleased to present the 2024 Top 50 State Lobbyists. Featured Article: Championing Inclusivity: Expanding Pathways to ...